Who we are

About us

Paracrine Therapeutics is a clinical-stage biotech company. Our core focus lies in harnessing the potential of Mesenchymal Stem Cell (MSC) exosomes to better the lives of people. Our company was founded by academic scientists with long experience in MSC exosomes research, and who are globally recognized as the top 0.1% in the exosome domain by Clarivate for consecutive years – 2021, 2022, and 2023 (Clarivate Highly Cited Researcherâ„¢).


Paracrine Therapeutics is dedicated to becoming a provider of high quality MSC exosome products, using robust manufacturing processes to enhance the quality of life for patients.

Paracrine Therapeutics places an emphasis on values. At Paracrine Therapeutics, we expect:

-Integrity and Responsibility
-Leadership in scientific excellence

Shopping Cart
Scroll to Top